MEET THE TEAM

thomas_wilkinson_from_neuronova
Founder & CEO
Builder, visionary, and believer in better solutions. After losing his brother to a methadone overdose, Thomas saw firsthand the flaws in addiction recovery. His own journey through anxiety and medication dependency led him to NeuroNova—a breakthrough that helped him heal naturally. Now, he’s on a mission to bring real, drug-free mental health solutions to the world.
kyle_bills_with_neuronova
Research Team
Dr. Bills is a neuroscientist and clinician specializing in migraine, brain injury, and addiction recovery. His research bridges neuroscience, AI, and clinical trials, and he's spent years developing non-pharmacological solutions for mental and neurological health.
At NeuroNova, he leads scientific innovation and clinical strategy.
scott_steffensen_with_neuronova
Research Team

Dr. Scott Steffensen, PhD

Dr. Steffensen is a nationally funded researcher with over 30 years of experience studying the neurobiology of addiction. His work focuses on how substances like alcohol and nicotine affect the brain—and how to reverse that damage. Driven by both science and personal experience, he helped pioneer NeuroNova’s groundbreaking technology to offer a new path to healing.
1692074366516
Head of Operations

Benny Burnett

Benny blends data-savvy strategy with people-first leadership to drive real growth and transformation. With a background in operations, finance, creative campaigns, and legal team rebuilds, he brings an ability to simplify complexity and spark change. Whether mentoring teams or optimizing processes, Benny’s mission is clear: help others thrive and build what’s next—together.
corbin_church_of_neuronova
Advisor

Corbin Church

A lifelong entrepreneur and impact-driven investor, Corbin has built and sold multiple companies over the past 30 years. Now, through ventures like iHub and NeuroNova, he’s focused on empowering innovators and driving solutions that change lives. Alongside his wife Kara, he’s also deeply committed to humanitarian work and cancer research.

Benny Burnett